You are on page 1of 1

FINANCIAL

FAST FACTS
2014 FINANCIAL REVENUE BY
HIGHLIGHTS SEGMENT

1%
$Millions (except per share data) 2014 2013 2012
15%
Net Revenue $ 4,785 $ 4,561 $ 4,336

Net Income Attributable to Zoetis $ 583 $ 504 $ 436 17% 43%


Diluted Earnings per Share $ 1.16 $ 1.01 $ 0.87

Net Cash Provided by Operating Activities $ 626 $ 681 $ 454


24%
Research & Development Expenses $ 396 $ 399 $ 409
United States 43%
Europe, Africa and Middle East 24%
Total Assets $ 6,607 $ 6,558 $ 6,262
Canada and Latin America 17%
Asia Pacific 15%
Client Supply Services 1%

REVENUE BY REVENUE BY REVENUE BY PRODUCT REVENUE BY


SPECIES1 PRODUCT CATEGORY1 CONCENTRATION1 TOP MARKETS1
Top three
products: 21%

3%
34% 37% 17% 29% 24%
39% 43%
10% 2%

61%
2%
2%
2%
2% 15% 26%
3%

12% 15%
3%
4%
4% 4% 7%

Cattle 37% Anti-infectives 29% Top ten product lines 39% United States 43% Germany 3%
Swine 15% Vaccines 26% All other product lines 61% Brazil 7% China 2%
Poultry 12% Parasiticides 15% Canada 4% Japan 2%
Other Livestock 2% Medicated feed additives 10% Australia 4% Italy 2%
Companion animal 34% Other pharmaceuticals 17% United Kingdom 4% Spain 2%
Other non-pharmaceuticals 3% France 3% Other 24%

1
Revenue charts exclude revenue associated with Client Supply Services, which represented 1% of total 2014 revenue.

For more information, visit www.zoetis.com